Autonomic Nervous System: Sympathetic, Parasympathetic, and Clinical Pharmacology
A clinical anatomy reference for the autonomic nervous system — the two divisions, their cell-body origins, neurotransmitters and receptors, and the drug classes that target each branch.
Learning Objectives
- ✓Distinguish sympathetic and parasympathetic anatomy by cell-body origin and target.
- ✓Map neurotransmitters (ACh, NE) to receptors (nicotinic, muscarinic, alpha, beta) by location.
- ✓Connect autonomic anatomy to clinical pharmacology (vasopressors, anticholinergics, beta-blockers).
1. Direct Answer: Two Divisions, Opposite Effects, Different Origins
The autonomic nervous system (ANS) operates the visceral, cardiovascular, and metabolic functions of the body involuntarily. It has two divisions with opposing effects on most organs. SYMPATHETIC — the “fight-or-flight” system — accelerates heart rate, dilates pupils and bronchi, constricts most blood vessels, and shifts blood from gut to muscle. Cell bodies of sympathetic preganglionic neurons sit in the INTERMEDIOLATERAL CELL COLUMN of the spinal cord T1 through L2-L3 (THORACOLUMBAR origin). PARASYMPATHETIC — the “rest-and-digest” system — slows heart rate, constricts pupils and bronchi, stimulates digestion and gut motility, and supports erection and bladder emptying. Cell bodies of parasympathetic preganglionic neurons sit in CRANIAL NERVE NUCLEI III, VII, IX, X and the SACRAL CORD S2-S4 (CRANIOSACRAL origin). Both divisions are TWO-NEURON systems: preganglionic and postganglionic. Preganglionic neurons in BOTH divisions release ACETYLCHOLINE onto NICOTINIC receptors in the ganglion. Postganglionic neurons release ACETYLCHOLINE (parasympathetic) or NOREPINEPHRINE (sympathetic) at the target organ — with one famous exception: sympathetic postganglionic fibers to sweat glands release ACETYLCHOLINE (onto muscarinic receptors), which is why anticholinergics dry sweating.
Key Points
- •Sympathetic: thoracolumbar (T1-L2). Parasympathetic: craniosacral (III, VII, IX, X + S2-S4).
- •Ganglia: ACh + nicotinic in BOTH divisions.
- •Target: ACh + muscarinic (parasympathetic); NE + alpha/beta (sympathetic). Sweat glands are the cholinergic sympathetic exception.
2. Sympathetic Anatomy: Thoracolumbar Outflow and Ganglia
Preganglionic sympathetic neurons exit the spinal cord through the ventral roots T1-L2, enter the spinal nerve, and pass through the WHITE RAMUS COMMUNICANS into the SYMPATHETIC CHAIN (paravertebral ganglia running alongside the vertebral column). Three options then exist. (1) Synapse in the chain ganglion at the same level. (2) Ascend or descend in the chain to synapse at a different level. (3) Pass through the chain and synapse in a PREVERTEBRAL (collateral) ganglion (celiac, superior mesenteric, inferior mesenteric ganglia) closer to the target organ. Postganglionic fibers then leave via GRAY RAMUS COMMUNICANS to rejoin spinal nerves and reach blood vessels and skin, or travel as splanchnic nerves to abdominal viscera. The ADRENAL MEDULLA is a special case — it is functionally a sympathetic ganglion with no postganglionic neuron; preganglionic fibers synapse directly on chromaffin cells that secrete epinephrine (80%) and norepinephrine (20%) into the bloodstream.
Key Points
- •Preganglionics T1-L2 → white ramus → sympathetic chain.
- •Postganglionics → gray ramus → spinal nerve OR via splanchnics to abdomen.
- •Adrenal medulla: preganglionic fiber directly synapses on chromaffin cells.
3. Parasympathetic Anatomy: Craniosacral Outflow
Cranial parasympathetic outflow runs in four cranial nerves. CN III (oculomotor) → Edinger-Westphal nucleus → ciliary ganglion → constricts pupil and accommodates lens. CN VII (facial) → superior salivatory nucleus → pterygopalatine and submandibular ganglia → lacrimal, nasal, sublingual, submandibular glands. CN IX (glossopharyngeal) → inferior salivatory nucleus → otic ganglion → parotid gland. CN X (vagus) → dorsal motor nucleus → ganglia in the wall of target organs → thoracic and abdominal viscera through the splenic flexure of the colon. Sacral parasympathetic outflow exits S2-S4 as the PELVIC SPLANCHNIC NERVES to ganglia in the wall of pelvic viscera — distal colon (from the splenic flexure), bladder, and sexual organs. Parasympathetic preganglionic fibers are LONG and postganglionic fibers are SHORT (because the ganglia sit on or in the target organ), the opposite of the sympathetic pattern.
Key Points
- •Cranial parasympathetic: CN III, VII, IX, X via four cranial ganglia.
- •Vagus (CN X) supplies thoracic and abdominal viscera up to splenic flexure.
- •Sacral parasympathetic (S2-S4) via pelvic splanchnics serves distal colon, bladder, sex organs.
4. Receptors at the Target Organ
NICOTINIC receptors are ionotropic and gate sodium and potassium channels. Two subtypes: N_N (in autonomic ganglia of both divisions and the adrenal medulla) and N_M (at neuromuscular junctions of skeletal muscle). MUSCARINIC receptors are metabotropic (G-protein-coupled) with five subtypes. M1, M3, M5 couple to Gq (increase IP3 and DAG, increase intracellular calcium). M2, M4 couple to Gi (decrease cAMP). M1 is in CNS and gastric parietal cells (gastric acid). M2 is in cardiac SA and AV nodes (slow heart rate). M3 is in smooth muscle and glands (constrict bronchi, stimulate secretion). ADRENERGIC receptors come in alpha and beta. Alpha-1 (Gq): vascular smooth muscle (vasoconstrict), bladder sphincter (contract), pupil dilator. Alpha-2 (Gi): presynaptic auto-inhibition, platelets, pancreatic beta cells (inhibit insulin). Beta-1 (Gs): cardiac (increase rate and contractility), kidney (renin). Beta-2 (Gs): bronchial smooth muscle (dilate), uterus (relax), skeletal muscle vessels (dilate), liver (glycogenolysis). Beta-3 (Gs): adipose (lipolysis).
Key Points
- •Muscarinic M1-M3-M5 → Gq; M2-M4 → Gi.
- •Alpha-1 → Gq (vasoconstrict); alpha-2 → Gi (auto-inhibit).
- •Beta-1 → Gs (heart, renin); Beta-2 → Gs (bronchodilate, glycogenolysis); Beta-3 → adipose.
5. Clinical Pharmacology by Receptor
ALPHA-1 AGONISTS (phenylephrine, midodrine) constrict blood vessels and raise blood pressure; used for hypotension. ALPHA-1 ANTAGONISTS (terazosin, tamsulosin) relax vascular and bladder neck smooth muscle; used for hypertension and BPH. ALPHA-2 AGONISTS (clonidine, dexmedetomidine) suppress central sympathetic outflow; used for hypertension and sedation. BETA-1 SELECTIVE BLOCKERS (metoprolol, bisoprolol, atenolol) decrease heart rate and contractility; used for hypertension, angina, heart failure. NON-SELECTIVE BETA BLOCKERS (propranolol) also block beta-2 — caution in asthma. BETA-2 AGONISTS (albuterol, salmeterol) bronchodilate; cornerstone of asthma management. MUSCARINIC ANTAGONISTS (atropine, ipratropium, oxybutynin) cause "dry as a bone, hot as a hare, blind as a bat, mad as a hatter, red as a beet" — used for bradycardia, COPD, urge incontinence, and motion sickness. CHOLINESTERASE INHIBITORS (donepezil, pyridostigmine, neostigmine) increase synaptic ACh; used in Alzheimer’s, myasthenia gravis, and to reverse non-depolarizing muscle relaxants.
Key Points
- •Alpha-1 agonists raise BP (phenylephrine); antagonists treat BPH (tamsulosin).
- •Beta-1 blockers (metoprolol) for HTN, angina, HF; beta-2 agonists (albuterol) for asthma.
- •Muscarinic antagonists dry secretions and dilate pupils; cholinesterase inhibitors do the opposite.
6. Horner Syndrome and Three-Neuron Sympathetic Pathway
The sympathetic supply to the face is a THREE-NEURON pathway. First-order neuron: hypothalamus to lateral horn of upper thoracic cord (T1-T2). Second-order neuron: T1-T2 cord through brachial plexus and over the lung apex to the superior cervical ganglion. Third-order neuron: superior cervical ganglion to the face along the internal carotid artery. Damage anywhere produces HORNER SYNDROME — ipsilateral PTOSIS (Muller’s muscle paralysis), MIOSIS (pupillary dilator failure), and ANHIDROSIS (loss of sweating, depending on the level). Causes by level: first-order (brainstem stroke, lateral medullary syndrome), second-order (Pancoast tumor at lung apex, carotid dissection, thoracic surgery), third-order (cavernous sinus pathology, internal carotid pathology). The level can be inferred from the pattern of anhidrosis and other associated findings, with pharmacologic testing (cocaine, apraclonidine, hydroxyamphetamine) confirming the diagnosis and helping localize.
Key Points
- •Horner = ptosis, miosis, anhidrosis from sympathetic interruption.
- •Three-neuron pathway: hypothalamus → T1-T2 → superior cervical ganglion → face.
- •Pancoast tumor classically causes second-order Horner syndrome.
7. Using AnatomyIQ for Autonomic Clinical Cases
Describe an autonomic clinical pattern — Horner syndrome features, anticholinergic toxidrome, autonomic dysreflexia, or cholinergic crisis — and AnatomyIQ ranks the most likely lesion location, identifies the involved receptors, and lists the targeted pharmacotherapy or antidote. This content is for educational purposes only.
Key Points
- •Autonomic clinical pattern → ranked lesion location.
- •Involved receptors identified for each presenting pattern.
- •Targeted pharmacotherapy and antidote prompts.
High-Yield Facts
- ★Sympathetic: thoracolumbar T1-L2; Parasympathetic: craniosacral (III, VII, IX, X + S2-S4).
- ★BOTH divisions release ACh at the ganglion (nicotinic).
- ★Sympathetic postganglionic to sweat glands releases ACh (muscarinic) — the exception.
- ★Alpha-1 = vasoconstrict; Beta-1 = heart; Beta-2 = bronchodilate.
- ★Horner: ptosis, miosis, anhidrosis from sympathetic interruption.
Practice Questions
1. A patient with a right lung apex tumor develops ipsilateral ptosis, miosis, and anhidrosis of the upper trunk. Which neuron level is affected, and why this anhidrosis pattern?
2. What is the pharmacologic rationale for using atropine in symptomatic bradycardia?
3. Why is propranolol contraindicated in asthma?
FAQs
Common questions about this topic
Embryologically and functionally, the chromaffin cells of the adrenal medulla are modified postganglionic sympathetic neurons. Preganglionic sympathetic fibers (T5-T11 splanchnic) synapse directly on chromaffin cells using ACh and nicotinic receptors, just like at any other sympathetic ganglion. The chromaffin cells then secrete epinephrine (80%) and norepinephrine (20%) into the bloodstream instead of releasing them at a synaptic cleft.
In injuries above T6, descending sympathetic control of the lower body is interrupted but parasympathetic control via the vagus remains intact. The result is AUTONOMIC DYSREFLEXIA: a noxious stimulus below the lesion (often bladder distension or fecal impaction) triggers reflex sympathetic outflow that produces hypertensive crisis in the lower body, which the vagus responds to by slowing the heart. The patient develops sudden severe hypertension, bradycardia, sweating above the lesion, and risk of stroke. Emergent treatment is removing the noxious stimulus.
SLUDGE is the mnemonic for muscarinic (cholinergic) excess: Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis. Anticholinergic toxicity produces the opposite: dry mouth, dry eyes, urinary retention, constipation, no GI symptoms. Combined with the central effects (confusion, delirium, hyperthermia from impaired sweating, mydriasis), it produces the classic "dry as a bone, hot as a hare, blind as a bat, mad as a hatter, red as a beet" toxidrome.
Neostigmine — a cholinesterase inhibitor — increases acetylcholine at the neuromuscular junction, displacing the non-depolarizing blocker (rocuronium, vecuronium, cisatracurium) from the nicotinic receptor. It is co-administered with glycopyrrolate, a quaternary muscarinic antagonist that prevents the bradycardia and bronchospasm that would result from increased ACh at muscarinic receptors. Sugammadex, a cyclodextrin that encapsulates rocuronium and vecuronium directly, has largely supplanted neostigmine for those agents in modern practice.
Describe the autonomic clinical pattern — Horner syndrome, autonomic dysreflexia, anticholinergic toxidrome — and AnatomyIQ ranks the most likely lesion location or toxic agent, identifies the involved receptors, and suggests targeted pharmacotherapy or antidote. The three-neuron Horner pathway is mapped with the differential by level. This content is for educational purposes only.